NICFF yields 5.30% · JNJ yields 2.14%● Live data
📍 NICFF pulled ahead of the other in Year 1
Combined, NICFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NICFF + JNJ for your $10,000?
Nichias Corporation manufactures and sells thermal insulation materials primarily in Japan. It operates in five segments: Energy and Industrial Plants, Industrial Products, Advanced Products, Autoparts, and Building Materials. The company offers gaskets and packings, including non-asbestos gaskets and packings, rubber type gaskets, other seal products, and peripheral function materials; and thermal insulation materials, such as fiber products, high performance thermal insulation materials, heat-insulation boards, and cryogenic insulation materials, as well as thermal insulation materials for molten aluminum. It also provides various fluoropolymer materials, processed products, and corrosion-resistant linings, as well as tubes, hoses, and bellows; filter products and environmental equipment; and auto parts comprising sealing materials, retaining parts/materials, and sound-proofing parts/materials, as well as heat-protection products, control parts, and materials. In addition, the company offers building materials for buildings and housing; and undertakes hot and cold insulation, refractory, electric heater tracing, acoustic insulation, and aerogel heat-insulation works. Further, it provides furniture sliding pads, and friction and agricultural materials. The company serves electric power and gas; waste incineration plants; chemical, petroleum refinery, and petrochemical; steel and non-ferrous metals; aluminum casting and processing; paper; building and housing construction; semiconductor and flat panel display; foods and pharmaceutical; medical equipment; electric equipment; aerospace; automobiles; ship building, maintenance, and repair; industrial equipment; and others industries. Nichias Corporation was incorporated in 1896 and is headquartered in Tokyo, Japan.
Full NICFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.